July 6th- Beyond the Webinar: Fertility After CAR-T Cell Therapy: Moving Beyond Survival Toward Survivorship

CME Congresses .

July 6th- Beyond the Webinar: Fertility After CAR-T Cell Therapy: Moving Beyond Survival Toward Survivorship

July 2nd- MajesTEC-5: Is Teclistamab Moving to the Frontline of Multiple Myeloma?

CME Congresses .

July 2nd- MajesTEC-5: Is Teclistamab Moving to the Frontline of Multiple Myeloma?

June 25th- Beyond the webinar: VEXAS Syndrome: When Inflammation Becomes Clonal Hematology

CME Congresses .

June 25th- Beyond the webinar: VEXAS Syndrome: When Inflammation Becomes Clonal Hematology

June 19th- Post-ASCO and EHA 2026: Multiple Myeloma at the Immunotherapy Crossroads

CME Congresses .

June 19th- Post-ASCO and EHA 2026: Multiple Myeloma at the Immunotherapy Crossroads

June 22nd- Can an All-Oral Combination Change the Treatment Landscape of Relapsed/Refractory DLBCL?

CME Congresses .

June 22nd- Can an All-Oral Combination Change the Treatment Landscape of Relapsed/Refractory DLBCL?

June 14th- LIVE from #EHA26- SUCCESSOR-2: Has Mezigdomide Just Redefined Relapse Therapy in Multiple Myeloma?

CME Congresses .

June 14th- LIVE from #EHA26- SUCCESSOR-2: Has Mezigdomide Just Redefined Relapse Therapy in Multiple Myeloma?

June 13th- LIVE from #EHA26- MonumenTAL-3: is Talquetamab Redefining Early Relapse Myeloma?

CME Congresses .

June 13th- LIVE from #EHA26- MonumenTAL-3: is Talquetamab Redefining Early Relapse Myeloma?

June 13th- LIVE from #EHA26- frontMIND: The First Real Challenge to R-CHOP in High-Risk DLBCL?

CME Congresses .

June 13th- LIVE from #EHA26- frontMIND: The First Real Challenge to R-CHOP in High-Risk DLBCL?

June 10th- Dr. Rahul Banerjee- Elra real world

CME Congresses .

June 10th- Dr. Rahul Banerjee- Elra real world

June 8th- Beyond the Webinar: Coagulopathy in Acute Leukemia: When Minutes Matter More Than Molecules

CME Congresses .

June 8th- Beyond the Webinar: Coagulopathy in Acute Leukemia: When Minutes Matter More Than Molecules